Response to letter to the editor by Moudgil-Joshi and Kaliaperumal
- PMID: 34596684
- PMCID: PMC8643463
- DOI: 10.1093/neuonc/noab215
Response to letter to the editor by Moudgil-Joshi and Kaliaperumal
Comment in
-
Letter regarding Louis et al: The 2021 WHO Classification of Tumors of the Central Nervous System: A summary.Neuro Oncol. 2021 Dec 1;23(12):2120-2121. doi: 10.1093/neuonc/noab190. Neuro Oncol. 2021. PMID: 34596667 Free PMC article. No abstract available.
Comment on
-
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106. Neuro Oncol. 2021. PMID: 34185076 Free PMC article. Review.
-
Letter regarding Louis et al: The 2021 WHO Classification of Tumors of the Central Nervous System: A summary.Neuro Oncol. 2021 Dec 1;23(12):2120-2121. doi: 10.1093/neuonc/noab190. Neuro Oncol. 2021. PMID: 34596667 Free PMC article. No abstract available.
References
-
- Sonoda Y, Yokoo H, Tanaka S, Kinoshita M, Nakada M, Nishihara H; Committee for Molecular Diagnosis of the Japan Society of Brain Tumor Pathology . Practical procedures for the integrated diagnosis of astrocytic and oligodendroglial tumors. Brain Tumor Pathol. 2019;36(2):56–62. - PubMed
-
- Santosh V, Sravya P, Gupta T, et al. . ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas. Neurol India. 2019;67(1):173–182. - PubMed